Who Paid My Doc
Optimizer
Device Cardiovascular Device
PDI 00810003380098
General payments
$4,030,840
Research payments
$6,143,538
Through program year 2025, $4,030,840 in general payments and $6,143,538 in research payments were reported against Optimizer (Cardiovascular Device).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $887,439 | 4,504 |
| 2025 | Research | $1,513,302 | 827 |
| 2024 | General | $1,296,307 | 6,539 |
| 2024 | Research | $2,711,885 | 1,261 |
| 2023 | General | $1,840,412 | 12,788 |
| 2023 | Research | $1,099,865 | 309 |
| 2022 | General | $6,683 | 165 |
| 2022 | Research | $818,486 | 332 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 45 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
23,996 general · 2,729 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.